Glatiramer Acetate Follow-up in Participants From the Original Study for Safety and Effectiveness

- Relapsing-Remitting Multiple Sclerosis
- Completed

Study Title: Glatiramer Acetate (Copaxoneֲ®) Study to Follow Participants From the First Original Study for Safety and Effectiveness

Teva Identifier: GA-9004 | 01-9004

ClinicalTrials.gov Identifier: NCT00203021

Study Status: Completed

Trial Condition(s): Relapsing-Remitting Multiple Sclerosis

Interventions: Drug: Glatiramer acetate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years and older

Trial Duration: March 26, 1994 - February 28, 2018

Phase: Phase 4

Study Type

Interventional